This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20 - 26 November 2022 and includes updates on monitoring the FIFA World Cup in Qatar, cholera, COVID-19, diphtheria, Ebola virus disease, polio, Respiratory Syncytial Virus, seasonal influenza, monkeypox, and West Nile virus.
ESCAIDE 2022 is offered in a hybrid format to ensure inclusiveness and ease of participation from different countries with varying degrees of travelling limitations, and to contribute to environmental sustainability by reducing carbon footprints.
The purpose of this review was to identify and synthesise the existing evidence on effectiveness of interventions targeting people who inject drugs at two stages of the care cascade: linkage to care and adherence to treatment of HIV, hepatitis B/C and TB.
This report documents the process and outcome of the assessment and translation of the evidence into guidance recommendations on linkage to care and/or adherence to treatment for HCV, HIV and TB for the ECDC technical report, ‘A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs’.
This document reports on one of ECDC’s multi-country studies in the hospital setting to measure product-specific COVID-19 VE against any laboratory-confirmed SARS-CoV-2 infection among healthcare workers (HCWs) eligible for vaccination.